It was reported that ESRRG, a transcriptional activator, regulated the proliferation of breast cancer cells by directly binding to the response element in the promoter of DNA cytosine 5-methyltransferase 1 (DMNT1) [31]. Here, DNMT1 is linked to breast carcinoma.